Jonathan Allan insider trades

Open-market stock purchases and sales by Jonathan Allan, GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc, from SEC Form 4 filings since Mar 15, 2023.

Recent trades

DateStockTradeValue
Aug 18, 2026STOK Stoke Therapeutics, IncSold$86.9K
Aug 18, 2026STOK Stoke Therapeutics, IncSold$4.7K
Aug 14, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jun 16, 2026STOK Stoke Therapeutics, IncSold$43.6K
Mar 20, 2026STOK Stoke Therapeutics, IncSold$20.7K
Mar 20, 2026STOK Stoke Therapeutics, IncSold$292K
Mar 18, 2026STOK Stoke Therapeutics, IncSold$132K
Mar 18, 2026STOK Stoke Therapeutics, IncSold$10.6K
Mar 18, 2026STOK Stoke Therapeutics, IncSold$2.4K
Mar 17, 2026STOK Stoke Therapeutics, IncSold$81.1K
Mar 17, 2026STOK Stoke Therapeutics, IncSold$59.8K
Mar 15, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Mar 15, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Mar 15, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Feb 17, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Feb 17, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Dec 8, 2025STOK Stoke Therapeutics, IncSold$41.1K
Dec 8, 2025STOK Stoke Therapeutics, IncSold$87.3K
Dec 5, 2025STOK Stoke Therapeutics, IncSold$31.5K
Dec 5, 2025STOK Stoke Therapeutics, IncSold$169K
Dec 5, 2025STOK Stoke Therapeutics, IncSold$74.4K
Dec 4, 2025STOK Stoke Therapeutics, IncSold$6.1K
Dec 4, 2025STOK Stoke Therapeutics, IncSold$25.3K
Dec 3, 2025STOK Stoke Therapeutics, IncBought (not open market)—
Dec 3, 2025STOK Stoke Therapeutics, IncSold$27.2K

Companies traded

  • STOK Stoke Therapeutics, Inc: 37 sales, last Aug 18, 2026

Get free alerts when Jonathan Allan files a new trade →